Phrontline Biopharma Highlights Encouraging Preliminary Safety and Antitumor Activity of TJ101 Presented at ESMO 2026 and Announces Phase Ib Initiation
Preliminary responses observed in 6 of 8 evaluable urothelial carcinoma patients (75%),…
From Catapult to capital: NextFin Asia reaches first investment milestone with Indonesia's Finfra
First Catapult: Inclusion SE Asia participant to receive investment through NextFin Asia LUXEMBOURG, Oct. 30, 2026 /PRNewswire/ — The Luxembourg House of…